Tag Archive: Cancer Advances

Feb 15 2011

Early Oncology Partnering Forum

From 21-22 February 2011, Cato Research will be attending the Early Oncology Partnering Forum held in San Francisco, CA.  This conference facilitates and encourages discussion and collaborations between companies that are developing innovative products with more established companies as partners. The conference will begin with a Partnering Perspective Presentation.  Representatives from Amgen, Eli Lilly, and …

Continue reading »

Sep 23 2010

35th European Society for Medical Oncology Congress

Image via Wikipedia The annual European Society for Medical Oncology (ESMO) meeting brings together medical oncologists from both Europe and all parts of the world.  As per ESMO’s 2010 meeting President, Dr. David Kerr, announcement: The ESMO Congress is a magnetic meeting point for worldwide medical oncology specialists and the ideal forum to present and …

Continue reading »

May 12 2010

Approval of Therapeutic Cancer Vaccines

Last month, Dendreon was granted approval for Provenge®, the first cell based cancer vaccine for treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer.  Provenge is the first cancer treatment that utilizes the strength of the patient’s own immune system to fight tumors.  This approval could mark the beginning of a …

Continue reading »